ITIH5 and exocrine pancreatic carcinoma: Young et al. showed that a modified ITIH5 protein, which lacks the signal peptide necessary for secretion, still has similar effects as the unmodified full-length ITIH5 protein in cellular models of pancreatic carcinoma, suggesting that ITIH5 may also act intracellularly [24].